Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.2 -2.44%
Market Cap
$53.3M
Price Target
Refer to Report
Volume
1.4M
52wk Range
$0.79 - $6.98
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.